Yakira Capital Management’s Estrella Immunopharma ESLA Stock Holding History

Yakira Capital Management’s Portfolio ESLA Stock Details ESLA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-10,143	Closed	-$110K	–	372
2023 Q2	$110K	Hold	10,143	–	–	0.03%	157
2023 Q1	$108K	Hold	10,143	–	–	0.03%	169
2022 Q4	$104K	Buy	+10,143	New	+$103K	0.02%	185

Other funds holding ESLA

OCAM

Owl Creek Asset Management New York $1.38B AUM 59.67% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

MCP

Maso Capital Partners Hong Kong $60.9M AUM 0.32% 1-Year Est. Return

Yakira Capital Management's ESLA Position: Q3 2023 in Review

Yakira Capital Management sold out of Estrella Immunopharma (ESLA) in Q3 2023, closing a stake of 10,143 shares — an estimated $110K sold.

Yakira Capital Management first reported a position in ESLA in Q4 2022 and held it in 3 quarters. The position peaked at $110K in Q2 2023. 3 funds tracked by Wall St. Rank hold ESLA as of Q3 2023.

Yakira Capital Management reported no remaining Estrella Immunopharma position as of Q3 2023 after selling out during the quarter.
Yakira Capital Management sold 10,143 Estrella Immunopharma shares in Q3 2023, an estimated $110K.
Yakira Capital Management first reported a position in Estrella Immunopharma in Q4 2022 and held it in 3 quarters.
Yakira Capital Management's Estrella Immunopharma position peaked at $110K in Q2 2023.
3 funds tracked by Wall St. Rank held Estrella Immunopharma as of Q3 2023.

Based on Yakira Capital Management's 13F filing for Q3 2023, filed 13 Nov 2023.